Skip to main navigation Skip to search Skip to main content

Characterizing circulating tumor cells using affinity-based microfluidic capture and AFM-based biomechanics

  • New York University

Research output: Contribution to journalArticlepeer-review

7 Scopus citations

Abstract

Elasticity and bio-adhesiveness of circulating tumor cells (CTCs) are important biomarkers of cancer. CTCs are rare in blood, thus their capture and atomic force microscopy (AFM)-based biomechanical characterization require use of multifunctional microfluidic device. Here, we describe procedures for fabrication of such device, AFM-Chip, and give details on its use in affinity-based CTC capture, and integration with AFM via reversable physical assembly. In the AFM-Chip, CTC capture is efficient, and transition to AFM characterization is seamless with minimal cell loss. For complete details on the use and execution of this protocol, please refer to Deliorman et al. (2020).

Original languageEnglish
Article number101433
JournalSTAR Protocols
Volume3
Issue number2
DOIs
StatePublished - 17 Jun 2022

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Atomic Force Microscopy (AFM)
  • Biotechnology and bioengineering
  • Cell isolation
  • Single Cell

Fingerprint

Dive into the research topics of 'Characterizing circulating tumor cells using affinity-based microfluidic capture and AFM-based biomechanics'. Together they form a unique fingerprint.

Cite this